Press Releases
10 hours ago
REPRONOVO APPOINTS MARK ALTMEYER AS CHAIRMAN OF THE BOARD
Indeterminate
GlobeNewswire, Inc.
Mar. 12, 2026
Aalberts N.V.: Aalberts completes divestment Broen in Denmark
Indeterminate
GlobeNewswire, Inc.
8 hours ago
Feed Additives Market Set to Reach $67.90 Billion by 2031 Driven by Rising Demand for Animal Nutrition
Indeterminate
GlobeNewswire, Inc.
Feb. 28, 2026
Denmark Targets Ukrainian Refugees with Policy Changes
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Mar. 19, 2026
Nordic MSPs Can Now Access Heimdal's Unified Security and Compliance Platform Through Elovade
Neutral
EIN Presswire
Mar. 2, 2026
Sweden, Denmark Are Open to Hosting NATO Nuclear Arms
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Feb. 19, 2026
Denmark's King Frederik X Makes Greenland Visit
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Mar. 19, 2026
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
Indeterminate
GlobeNewswire, Inc.
Feb. 19, 2026
Denmark’s King Visits Greenland to Signal Support Amid Arctic Spotlight
Indeterminate
MENAFN
Owner: Sawsan Dababneh
15 hours ago
Galimedix Therapeutics presents strong pharmacokinetic profile of next-generation oral Alzheimer’s candidate at AD/PD™ 2026
Indeterminate
GlobeNewswire, Inc.
15 hours ago
AsiaCorp and Whiteflock Brand Management Form Strategic Partnership to Expand Global Brands in India
Neutral
EIN Presswire
Mar. 19, 2026
Notice to convene Evaxion’s Annual General Meeting
Indeterminate
GlobeNewswire, Inc.
Mar. 18, 2026
Nordic MSPs Can Now Access Heimdal's Unified Security and Compliance Platform Through Elovade
Neutral
EIN Presswire
Mar. 18, 2026
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
Indeterminate
GlobeNewswire, Inc.
Mar. 19, 2026
National Center on Education and the Economy (NCEE) Names Global High Performing Countries in Education
Indeterminate
GlobeNewswire, Inc.
Mar. 19, 2026
NetraMark Unveils AI-Discovered Treatment-Responsive Subgroups in A4 Alzheimer’s Trial at AD/PD Conference
Indeterminate
GlobeNewswire, Inc.
Mar. 19, 2026
Priavoid Presents Preclinical Proof-of-Concept for PRI-101 Demonstrating α-synuclein Aggregate Disassembly at AD/PD™ 2026
Indeterminate
GlobeNewswire, Inc.